| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-223 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 |
| filingDate |
2004-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_921b2868b64bb6fcbb21971a6adbd481
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1547ec363b6e7b8b940acab8d304fef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b270fe70367b718c04270616233dafc7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c042ee302ffb023b1c8af3efb38d253 |
| publicationDate |
2004-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004230122-A1 |
| titleOfInvention |
Ultrasound imaging |
| abstract |
A combined preparation comprising: n i) an ultrasound contrast agent capable of accumulation in tissue microvasculature; and n ii) a pharmacologically effective amount of a vasodilator drug n may be used in perfusion imaging, especially of the myocardium. The contrast agent accumulates in tissue in concentrations related to the regional rate of tissue perfusion, and the vasodilator drug enhances distinction between normally perfused and underperfused tissue. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8192364-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011082374-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9427396-B2 |
| priorityDate |
1997-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |